R&D expenses of Intellia Therapeutics 2014-2023
Intellia Therapeutics spent some 435 million U.S. dollars on research and development in 2023, compared to 11 million U.S. dollars back in 2015. Intellia is a biotech company from Massachusetts that produces therapeutics using CRISPR technology.